# GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

> **NCT01933516** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 6 (actual)

## Conditions studied

- Indolent B-cell Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** GP2013

## Key facts

- **NCT ID:** NCT01933516
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933516, "GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01933516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*